Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 118 clinical trials
Featured trial
Do You Take Two Insulins to Treat Your Type 2 Diabetes?

regulate blood sugar levels through the use of a Continuous Glucose Monitoring (CGM) System. All participants will continue or start taking Basaglar insulin (glargine-U100). All participants will also start

continuous glucose monitoring
hemoglobin a1c
metformin
sugars
lantus
  • 6 views
  • 22 Oct, 2021
  • 1 location
Featured trial
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

  • 808 views
  • 25 Mar, 2021
  • 1 location
Continuous Glucose Monitoring in At-Risk Newborns

to test glucose levels on bedside glucometers; however, continuous glucose monitoring (CGM, currently not approved for clinical use in babies), via a small sensor placed in the thigh (only 1 needle

  • 0 views
  • 15 Oct, 2021
  • 1 location
Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.

The overall objective of this research study is to examine the effectiveness of the use of CGM vs. SMBG in persons with insulin-treated type 2 diabetes on glycemic variables and patient reported outcomes on treatment satisfaction, health behavior and wellbeing. The independent effect of peer-support will also be studied.

  • 0 views
  • 27 Jan, 2021
  • 1 location
Accuracy of the Dexcom G6 Continuous Glucose Monitoring System Following Cardiac Surgery

This is a prospective longitudinal study to study the agreement between a novel continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study

  • 0 views
  • 22 May, 2021
  • 1 location
Efficacy and Safety of Highland Barley Diet on Glucose Variability in Patients With Type 1 Diabetes Mellitus

treatment will continue for 12 weeks. The primary efficacy measure is the change in MAGE from continuous glucose monitoring system at 12 weeks. The study consists of 3 periods: a 1-week screening (period A

  • 0 views
  • 11 Sep, 2021
  • 1 location
Low-carbohydrate Diet in Children With Type 1 Diabetes

objective of the trial is the change in continuous glucose monitoring time in target range 3.9-10.0 mmol/l (TIR) in a 5-week period on LCD as opposed to a 5-week period on recommended carbohydrate diet (RCD

  • 0 views
  • 21 Oct, 2021
  • 1 location
Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

continuous glucose monitoring (CGM)) sensor placed in their arm which they will wear for 72 hours during the study. The glucose values from the CGM, collected during the time it is worn, will be downloaded

  • 0 views
  • 31 Dec, 2021
  • 1 location
Effectiveness of CGMS vs. Self-monitoring Blood Glucose (SMBG) in Woman With Gestational Diabetes

pregnancy with diabetes. When compared with routine standard antenatal care, continuous glucose monitoring system (CGMS) guided treatments should signicantly improve glycemic control, lower infant birth

  • 0 views
  • 29 Oct, 2021
  • 1 location
Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet

12 weeks and receive all their meals by meal delivery.They will share continuous glucose monitoring data with the study team and be in close communication to adjust insulin doses as needed. All

  • 1 views
  • 18 Nov, 2021
  • 1 location